Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries

Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries

Abstract Background To describe variations in treatment patterns, clinical outcomes, patient-reported outcomes (PRO), and physician and patient satisfaction in patients with moderate-to-severe ulcerative colitis (UC) treated with tofacitinib in a real-world setting. Methods Data were drawn from the...

Full description

Bibliographic Details
Main Authors: Alessandro Armuzzi, Ailsa Hart, Joseph C. Cappelleri, Nadir Mammar, Peter Hur, Benjamin Hoskin, Fritha Hennessy, Gary Milligan, Axel Dignass
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Gastroenterology
Subjects:
Ulcerative colitis
IBD
Disease burden
Tofacitinib
Treatment outcomes
Real-world
Online Access:https://doi.org/10.1186/s12876-023-02640-7

Internet

https://doi.org/10.1186/s12876-023-02640-7

Similar Items